GLASGOW AND CLYDE MEDICAL SERVICES LTD
Opportunity 76/100 (strong), bankability 70/100. Strong seller-intent signal (60/100, director aged 65). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 |
|---|---|
| Average employees | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (5 events)Click to expand
- 2025-10-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-02-13🏢Company incorporatedAs GLASGOW AND CLYDE MEDICAL SERVICES LTD
- 2024-02-13➕MCLEAN, Jane Elizabeth appointeddirector
- 2024-02-13➕SYKES, Glen Campbell, Dr appointeddirector
- 2024-02-13📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder age: Director aged approximately 65 — succession pressure is live.
- +Young company: Only 2.2 years old — management layer unlikely to be developed.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 65. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Glen Campbell Sykes Individual · British · DOB 12/1961 · age 65 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 13/02/2024 |
Mrs Jane Elizabeth Mclean Individual · British · DOB 11/1965 · age 61 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 13/02/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · PA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ISLAND CARE SERVICES C.I.C.→ SC844299 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| JPM AESTHETICS LTD→ SC677070 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| KIDOLOGY GREENOCK LIMITED→ SC838344 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| LITTLEINCH LIMITED→ SC111248 · est 1988 · no financials extracted | — | — | — | — | 37y | — | — |
| OMAR JAMMEH LIMITED→ SC731747 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| OUR CARE (CAIRNDOW) CIC→ SC799095 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| PARE LE CORPS LTD→ SC832588 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| PHOENIX ABBEY LIMITED→ SC643484 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| RADFORD-TROTTER LIMITED→ SC605805 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| RAMH→ SC141458 · est 1992 · no financials extracted | — | — | — | — | 33y | — | — |
| REHABVIBES LTD→ SC847199 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| REIKI READY LTD→ SC864335 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.